Maccarana M, et al., Domain structure of heparan sulfates from bovine organs, J Biol Chem
271, 17804–10 (1996).
Feyzi E, et al., Age-dependent modulation of heparan sulfate structure and function, J Biol Chem
273, 13395–8 (1998).
Moses J, Oldberg Å, Fransson L-Å, Initiation of glycosaminoglycan biosynthesis. Separate galactosylation and dephosphorylation pathways for phosphoxylosylated decorin protein and endogenous xyloside, Eur J Biochem
260, 879–84 (1999).
Prydz K, Dalen YKT, Synthesis and sorting of proteoglycans, J Cell Science
113, 193–205 (2000).
Selleck S, Proteoglycans and pattern formation. Sugar biochemistry meets developmental genetics, Trends in Genetics
16, 206–12 (2000).
Moses J, Oldberg Å, Cheng F, Fransson L-Å, Biosynthesis of the proteoglycan decorin. Transient 2-phosphorylation of xylose during formation of the trisaccharide linkage region, Eur J Biochem
248, 521–6 (1997).
Moses J, Oldberg Å, Eklund E, Fransson L-Å, Biosynthesis of the proteoglycan decorin. Identification of intermediates in galactosaminoglycan assembly, Eur J Biochem
248, 767–74 (1997).
Olwin B, Rapraeger A, Repression of myogenic differentiation by a aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate, J Cell Biol
118, 631–9 (1992).
Yamaguchi Y, Mann DM, Ruoslahti E, Negative regulation of transforming growth factor-beta by the proteoglycan decorin, Nature
346, 281–4 (1990).
Jackson RL, Busch SJ, Cardin AD, Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes, Physiol Rev
71, 481–539 (1991).
Mahley RW, Ji Z, Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E, J Lipid Res
40, 1–16 (1999).
Olivecrona T, et al., New aspects on heparin and lipoprotein metabolism, Haemostasis
23, 150–60 (1993).
Camejo G, The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: Its possible role in atherogenesis, Adv Lip Res
19, 1–54 (1982).
Olsson U, et al., Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the apoB/E receptor, Arterioscler Thromb Vasc Biol
17, 149–55 (1997).
Borén J, et al., Identification of the principal proteoglycan binding site in LDL: A single point mutation in apolipoprotein B100 severely affects proteoglycan interaction without affecting LDL receptor binding, J Clin Invest
101, 2658–64 (1998).
Kovanen PT, Pentikainen MO, Decorin links low-density lipoproteins (LDL) to collagen: A novel mechanism for retention of LDL in the atherosclerotic plaque, Trends Cardiovasc Med
9, 86–91 (1999).
Camejo G, et al., Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells, J Biol Chem
268, 14131–7 (1993).
Iverius P, The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans, J Biol Chem
247, 2607–13 (1972).
Olsson U, Camejo G, Olofsson S, Bondjers G, Molecular parameters that control the association of low density lipoprotein apo B-100 with chondroitin sulphate, Biochim Biophys Acta
1097, 37–44 (1991).
Hurt-Camejo E, Camejo G, Sartipy P, Measurements of proteoglycan-lipoprotein interaction by gel mobility shift assay, Methods Mol Biol
110, 267–79 (1998).
Hurt-Camejo E, et al., Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages, J Lipid Res
31, 1387–98 (1990).
Ji Z, et al., Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells, J Biol Chem
268, 10160–7 (1993).
Fager G, et al., Human arterial smooth muscle cells in culture, Exp Cell Res
176, 319–35 (1988).
Sartipy P, et al., Binding of human phospholipase A2 type II to proteoglycans: Differential effect of glycosaminoglycans on enzyme activity, J Biol Chem
271, 26307–14 (1996).
Olsson U, Bondjers G, Camejo G, Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins, Diabetes
48, 616–22 (1999).
Fager G, et al., Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human smooth muscle cells, J Cell Physiol
163, 380–92 (1995).
Alves CS, Murao PAS, Interaction of high molecular weight chondroitin sulfate from human aorta with plasma low density lipoprotein, Atherosclerosis
73, 113–24 (1988).
Wight TN, The Vascular Extracellular Matrix (Lippincott Raven, Philadelphia, PA, 1996).
Smith EB, The relationship between plasma and tissue lipids in human atherosclerosis, Adv Lipid Res
12, 1–49 (1974).
Kulseth MA, et al., Serglycin expression during monocytic differentiation of U937–1 cells, Glycobiology
8, 747–53 (1998).
Olsson U, Camejo G, Bondjers G, Binding of a synthetic apolipoprotein B-100 peptide and peptide analogues to chondroitin 6-sulfate: Effects of the lipid environment, Biochemistry
32, 1858–65 (1993).
Anber V, et al., Influence of plasma lipid and LDL subfraction pro-file on the interaction between low density lipoprotein with human arterial proteoglycan, Atherosclerosis
1124, 261–71 (1996).
Mahley RW, Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease, Isr J Med Sci
32, 414–29 (1996).
Nielsen LB, Nordestgaard B, Stender S, Kjeldsen K, Aortic permeability to LDL as a predictor for aortic cholesterol accumulation in cholesterol-fed rabbits, Arterioscler Thromb
12, 1402–9 (1992).
Nielsen L, Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis, Atherosclerosis
123, 1–15 (1996).
Nielsen L, Stender S, Jauhianien M, Nordestgaard B, Preferential influx and decreased fractional loss of lipoprotein (a) in atherosclerosis compared with non-lesioned rabbit aorta, J Clin Invest
98, 563–71 (1996).
Wang Y, Kovanen PT, Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture, Circ Res
84, 74–83 (1998).
Zeng B, et al., Chylomicron remnant uptake is regulated by the expression and function of heparan sulfate proteoglycan in hepatoytes, J Lipid Res
39, 845–60 (1998).
Hawkins M, et al., Role of the glucosamine pathway in fat-induced insulin resistance, J Clin Invest
99, 2173–82 (1997).
Olsson U, et al., Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of type 2 diabetes, Diabetes
50, 2126–32 (2001).
Kelly JH, Darlington GJ, Modulation of the liver specific phenotype in the human hepatoblastoma line HepG2, In Vitro Cell Dev Biol
25, 217–22 (1989).
Javitt NB, HepG2 cells as a source for metabolic studies: Lipoprotein, cholesterol, and bile acids, FASEB J
4, 161–8 (1990).